🇺🇸 FDA
Patent

US 7541346

Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs

granted A61KA61K31/675A61P

Quick answer

US patent 7541346 (Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs) held by ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/675, A61P, A61P35/00